Quick Facts
FONT-SIZE Plus   Neg
Share SHARE
mail  E-MAIL

Spectrum Pharma Q4 Profit Up - Quick Facts

RELATED NEWS
Trade SPPI now with 
3/1/2012 7:28 AM ET

Spectrum Pharmaceuticals, Inc. (SPPI: Quote) reported fourth-quarter profit of $8.28 million or $0.13 per share versus $4.44 million or $0.08 per share last year.

Adjusted earnings per share were up to $0.24 from $0.19 in the same quarter last year.

On average, five analysts polled by Thomson Reuters expected the company to report earnings of $0.31 per share. Analysts' estimates typically exclude special items.

Total revenues grew to $52.98 million from $33.95 million in the prior-year quarter. Analysts estimated revenues of $52.73 million.

Click here to receive FREE breaking news email alerts for Spectrum Pharmaceuticals Inc and others in your portfolio

by RTT Staff Writer

For comments and feedback: editorial@rttnews.com

Business News

Editors Pick
Russian Foreign Minister Sergei Lavrov warned Wednesday that Moscow would retaliate strongly if its "interests" in Ukraine are attacked. He also criticized the Ukrainian administration for relaunching its so-called anti-terrorist operation in the east of the country a day earlier. Lavrov's remarks came in an interview with Russia Today, which published excerpts of the English-language interview to While selling pressure has remained relatively subdued, stocks continue to see modest weakness in mid-day trading on Wednesday. The losses on the day come on the heels of the upward trend seen over the past several sessions. The major averages have moved roughly sideways in recent trading, lingering in the red. While a majority of Kentucky voters approve of the way Rand Paul is handling his job as Senator, the results of New York Times/Kaiser Family Foundation poll showed that voters from the Bluegrass State have a more mixed view on Paul's potential run for president in 2016.
comments powered by Disqus
FREE Newsletters, Analysis & Alerts

 

Stay informed with our FREE daily Newsletters and real-time breaking News Alerts. Sign up to receive the latest information on business news, health, technology, biotech, market analysis, currency trading and more.